ArticleScientific reports2024

Machine learning based intratumor heterogeneity signature for predicting prognosis and immunotherapy benefit in stomach adenocarcinoma.

Hongcai Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.